Rabbit monoclonal [EPR4555] to VEGFB
Synthetic peptide within Human VEGFB aa 100-200. The exact sequence is proprietary.
- VEGFB recombinant protein
A trial size is available to purchase for this antibody.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents
This product is a recombinant rabbit monoclonal antibody.
Shipped at 4°C. Store at -20°C. Stable for 12 months at -20°C.
PBS 49%,Sodium azide 0.01%,Glycerol 50%,BSA 0.05%
Tissue culture supernatant
Our Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
||1/1000 - 1/10000. Detects a band of approximately 19 kDa (predicted molecular weight: 22 kDa).
Is unsuitable for ICC,IHC-P or IP.
Growth factor for endothelial cells. VEGF-B167 binds heparin and neuropilin-1 whereas the binding to neuropilin-1 of VEGF-B186 is regulated by proteolysis.
Expressed in all tissues except liver. Highest levels found in heart, skeletal muscle and pancreas.
Belongs to the PDGF/VEGF growth factor family.
VEGF-B186 is O-glycosylated.
Secreted. Secreted but remains associated to cells or to the extracellular matrix unless released by heparin.
Information by UniProt
There are 2 isoforms produced by alternative splicing.
- Vascular endothelial growth factor B antibody
- Vascular endothelial growth factor-related factor antibody
- VEGF B antibody
Western blot - Anti-VEGFB antibody [EPR4555] (ab110649)
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"